AAPL337.08-2.67 (-0.79%) ▼|ABBV264.24-0.97 (-0.37%) ▼|ABT104.16+0.47 (+0.45%) ▲|ACN185.26+1.54 (+0.84%) ▲|ADBE240.26+2.01 (+0.84%) ▲|AMAT472.79+0.33 (+0.07%) ▲|AMD614.43-9.35 (-1.50%) ▼|AMGN407.75-2.49 (-0.61%) ▼|AMT172.04-3.21 (-1.83%) ▼|AMZN248.64-6.34 (-2.49%) ▼|AVGO355.06-9.48 (-2.60%) ▼|AXP303.20-1.87 (-0.61%) ▼|BA202.00+4.28 (+2.16%) ▲|BAC55.89-0.32 (-0.56%) ▼|BKNG156.76-7.46 (-4.54%) ▼|BLK1,067.24+0.58 (+0.05%) ▲|BMY61.61-0.65 (-1.04%) ▼|BNY150.52+0.35 (+0.23%) ▲|BRK-B511.02+7.53 (+1.50%) ▲|C132.65+0.18 (+0.13%) ▲|CAT810.34+2.33 (+0.29%) ▲|CL86.15-0.90 (-1.03%) ▼|CMCSA22.85+0.43 (+1.90%) ▲|COF197.49-3.06 (-1.53%) ▼|COP128.57+3.30 (+2.63%) ▲|COST901.17+1.76 (+0.20%) ▲|CRM239.38+6.10 (+2.61%) ▲|CSCO106.34-0.11 (-0.10%) ▼|CVS86.07-1.03 (-1.18%) ▼|CVX205.93+3.52 (+1.74%) ▲|DE708.94+5.82 (+0.83%) ▲|DHR220.84-0.25 (-0.11%) ▼|DIS103.99+0.17 (+0.16%) ▲|DUK114.87-1.45 (-1.24%) ▼|EMR155.51+1.32 (+0.86%) ▲|FDX293.60-2.34 (-0.79%) ▼|GD345.42+2.03 (+0.59%) ▲|GE321.18+1.96 (+0.61%) ▲|GEV942.18-8.10 (-0.85%) ▼|GILD150.73-1.94 (-1.27%) ▼|GM84.14+0.69 (+0.83%) ▲|GOOG335.45-11.96 (-3.44%) ▼|GOOGL339.03-12.13 (-3.45%) ▼|GS937.23-12.26 (-1.29%) ▼|HD299.87-5.49 (-1.80%) ▼|HON212.57+0.72 (+0.34%) ▲|IBM235.07+3.69 (+1.59%) ▲|INTC120.60-3.26 (-2.63%) ▼|INTU287.63-4.72 (-1.61%) ▼|ISRG396.89-5.20 (-1.29%) ▼|JNJ267.24-1.96 (-0.73%) ▼|JPM338.26-1.74 (-0.51%) ▼|KO88.08-0.53 (-0.60%) ▼|LIN470.54+5.63 (+1.21%) ▲|LLY1,151.37-18.77 (-1.60%) ▼|LMT527.42+5.08 (+0.97%) ▲|LOW193.13-2.96 (-1.51%) ▼|LRCX306.87-3.76 (-1.21%) ▼|MA559.68+3.79 (+0.68%) ▲|MCD237.07-13.28 (-5.30%) ▼|MDLZ61.07-0.01 (-0.02%) ▼|MDT89.43-1.35 (-1.48%) ▼|META752.29+15.69 (+2.13%) ▲|MMM169.66+0.36 (+0.21%) ▲|MO69.46+0.82 (+1.19%) ▲|MRK147.99-2.93 (-1.94%) ▼|MS198.90-1.28 (-0.64%) ▼|MSFT499.40+1.40 (+0.28%) ▲|MU1,072.40-23.76 (-2.17%) ▼|NEE77.68-1.59 (-2.00%) ▼|NFLX71.68-0.48 (-0.67%) ▼|NKE35.85-0.25 (-0.69%) ▼|NOW140.10+3.10 (+2.26%) ▲|NVDA225.16-3.71 (-1.62%) ▼|ORCL146.47-2.73 (-1.83%) ▼|PEP129.78-1.41 (-1.07%) ▼|PFE28.18+0.25 (+0.88%) ▲|PG147.84-0.38 (-0.26%) ▼|PLTR191.18+6.19 (+3.35%) ▲|PM191.23+1.00 (+0.52%) ▲|QCOM197.30-0.97 (-0.49%) ▼|RTX193.90+2.91 (+1.52%) ▲|SBUX94.45-0.66 (-0.69%) ▼|SCHW100.26-0.09 (-0.09%) ▼|SO83.78-1.37 (-1.61%) ▼|SPG204.80-1.16 (-0.56%) ▼|T25.47+0.37 (+1.45%) ▲|TMO659.37+0.85 (+0.13%) ▲|TMUS166.52+4.11 (+2.53%) ▲|TSLA379.37+0.47 (+0.12%) ▲|TXN271.42+0.01 (+0.00%) ▲|UBER69.51-0.38 (-0.54%) ▼|UNH370.49-2.47 (-0.66%) ▼|UNP276.89+2.48 (+0.90%) ▲|UPS96.80+0.93 (+0.96%) ▲|USB58.91-0.54 (-0.90%) ▼|V361.86-0.18 (-0.05%) ▼|VZ46.90+0.45 (+0.97%) ▲|WFC82.36-0.79 (-0.95%) ▼|WMT110.27+0.15 (+0.14%) ▲|XOM160.94+2.23 (+1.41%) ▲|AAPL337.08-2.67 (-0.79%) ▼|ABBV264.24-0.97 (-0.37%) ▼|ABT104.16+0.47 (+0.45%) ▲|ACN185.26+1.54 (+0.84%) ▲|ADBE240.26+2.01 (+0.84%) ▲|AMAT472.79+0.33 (+0.07%) ▲|AMD614.43-9.35 (-1.50%) ▼|AMGN407.75-2.49 (-0.61%) ▼|AMT172.04-3.21 (-1.83%) ▼|AMZN248.64-6.34 (-2.49%) ▼|AVGO355.06-9.48 (-2.60%) ▼|AXP303.20-1.87 (-0.61%) ▼|BA202.00+4.28 (+2.16%) ▲|BAC55.89-0.32 (-0.56%) ▼|BKNG156.76-7.46 (-4.54%) ▼|BLK1,067.24+0.58 (+0.05%) ▲|BMY61.61-0.65 (-1.04%) ▼|BNY150.52+0.35 (+0.23%) ▲|BRK-B511.02+7.53 (+1.50%) ▲|C132.65+0.18 (+0.13%) ▲|CAT810.34+2.33 (+0.29%) ▲|CL86.15-0.90 (-1.03%) ▼|CMCSA22.85+0.43 (+1.90%) ▲|COF197.49-3.06 (-1.53%) ▼|COP128.57+3.30 (+2.63%) ▲|COST901.17+1.76 (+0.20%) ▲|CRM239.38+6.10 (+2.61%) ▲|CSCO106.34-0.11 (-0.10%) ▼|CVS86.07-1.03 (-1.18%) ▼|CVX205.93+3.52 (+1.74%) ▲|DE708.94+5.82 (+0.83%) ▲|DHR220.84-0.25 (-0.11%) ▼|DIS103.99+0.17 (+0.16%) ▲|DUK114.87-1.45 (-1.24%) ▼|EMR155.51+1.32 (+0.86%) ▲|FDX293.60-2.34 (-0.79%) ▼|GD345.42+2.03 (+0.59%) ▲|GE321.18+1.96 (+0.61%) ▲|GEV942.18-8.10 (-0.85%) ▼|GILD150.73-1.94 (-1.27%) ▼|GM84.14+0.69 (+0.83%) ▲|GOOG335.45-11.96 (-3.44%) ▼|GOOGL339.03-12.13 (-3.45%) ▼|GS937.23-12.26 (-1.29%) ▼|HD299.87-5.49 (-1.80%) ▼|HON212.57+0.72 (+0.34%) ▲|IBM235.07+3.69 (+1.59%) ▲|INTC120.60-3.26 (-2.63%) ▼|INTU287.63-4.72 (-1.61%) ▼|ISRG396.89-5.20 (-1.29%) ▼|JNJ267.24-1.96 (-0.73%) ▼|JPM338.26-1.74 (-0.51%) ▼|KO88.08-0.53 (-0.60%) ▼|LIN470.54+5.63 (+1.21%) ▲|LLY1,151.37-18.77 (-1.60%) ▼|LMT527.42+5.08 (+0.97%) ▲|LOW193.13-2.96 (-1.51%) ▼|LRCX306.87-3.76 (-1.21%) ▼|MA559.68+3.79 (+0.68%) ▲|MCD237.07-13.28 (-5.30%) ▼|MDLZ61.07-0.01 (-0.02%) ▼|MDT89.43-1.35 (-1.48%) ▼|META752.29+15.69 (+2.13%) ▲|MMM169.66+0.36 (+0.21%) ▲|MO69.46+0.82 (+1.19%) ▲|MRK147.99-2.93 (-1.94%) ▼|MS198.90-1.28 (-0.64%) ▼|MSFT499.40+1.40 (+0.28%) ▲|MU1,072.40-23.76 (-2.17%) ▼|NEE77.68-1.59 (-2.00%) ▼|NFLX71.68-0.48 (-0.67%) ▼|NKE35.85-0.25 (-0.69%) ▼|NOW140.10+3.10 (+2.26%) ▲|NVDA225.16-3.71 (-1.62%) ▼|ORCL146.47-2.73 (-1.83%) ▼|PEP129.78-1.41 (-1.07%) ▼|PFE28.18+0.25 (+0.88%) ▲|PG147.84-0.38 (-0.26%) ▼|PLTR191.18+6.19 (+3.35%) ▲|PM191.23+1.00 (+0.52%) ▲|QCOM197.30-0.97 (-0.49%) ▼|RTX193.90+2.91 (+1.52%) ▲|SBUX94.45-0.66 (-0.69%) ▼|SCHW100.26-0.09 (-0.09%) ▼|SO83.78-1.37 (-1.61%) ▼|SPG204.80-1.16 (-0.56%) ▼|T25.47+0.37 (+1.45%) ▲|TMO659.37+0.85 (+0.13%) ▲|TMUS166.52+4.11 (+2.53%) ▲|TSLA379.37+0.47 (+0.12%) ▲|TXN271.42+0.01 (+0.00%) ▲|UBER69.51-0.38 (-0.54%) ▼|UNH370.49-2.47 (-0.66%) ▼|UNP276.89+2.48 (+0.90%) ▲|UPS96.80+0.93 (+0.96%) ▲|USB58.91-0.54 (-0.90%) ▼|V361.86-0.18 (-0.05%) ▼|VZ46.90+0.45 (+0.97%) ▲|WFC82.36-0.79 (-0.95%) ▼|WMT110.27+0.15 (+0.14%) ▲|XOM160.94+2.23 (+1.41%) ▲|
17.7 C
New York
Wednesday, September 23, 2026

Tag: 1

newssourceFORcompanyinformationcontent1releasesmarket

IsoEnergy and Purepoint Extend High-Grade Mineralization at the Dorado JV with a 70 Metre Step-Out Peaking at 110,800 CPS

TORONTO, July 23, 2025 /CNW/ - IsoEnergy Ltd. (NYSE American: ISOU) (TSX: ISO) ("IsoEnergy") and Purepoint Uranium Group Inc. (TSXV: PTU) (OTC: PTUUF) ("Purepoint") are...

G Mining Ventures Provides Update on Gurupi Project Licensing Process in Brazil Following Court Ruling

BROSSARD, QC, July 23, 2025 /CNW/ - G Mining Ventures Corp. ("GMIN" or the "Corporation") (TSX: GMIN) (OTCQX: GMINF) is pleased to announce that...

4TEEN4 Doses First Patient in Phase 1b/2a Trial of Procizumab, a Monoclonal Antibody Targeting the Biological Driver of Shock

Hennigsdorf/ Berlin, July 23, 2025 – 4TEEN4 Pharmaceuticals GmbH today announced that the first patient has been dosed in a Phase 1b/2a PROCARD1 clinical trial evaluating its monoclonal antibody, procizumab, in patients with shock caused primarily by cardiogenic events. Shock is a life-threatening condition characterized by a sudden breakdown in circulatory function due to end-stage disease or acute events, which often leads to organ failure. With only symptomatic treatment options available, shock is associated with a high mortality rate of over 50%. The Phase 1b/2a trial is designed to identify a target dose for procizumab in preparation for further clinical development. In addition, the trial will provide signals of efficacy. In a Phase 1 study in healthy volunteers, procizumab was well tolerated.

Dimensional Fund Advisors Ltd. : Form 8.3 – UNITE GROUP PLC/THE – Ordinary Shares

FORM 8.3

Algorithmica Reports 35% Return in First Fiscal Year, Driven by Machine Learning Trading Technology

LUGANO, Switzerland, July 23, 2025 /PRNewswire/ -- Algorithmica, a cutting-edge technology provider of proprietary machine learning systems built upon the principles of Artificial Intelligence,...

Guidehouse Research Explores Evolving Electric Vertical Takeoff and Landing Technology Market

eVTOLs are on the verge of full commercial manufacturing and approval BOULDER, Colo., July 23, 2025 /PRNewswire/ -- A new report from Guidehouse Research explores electric vertical takeoff...

Form 8.5 (EPT/RI) – Apax Global Alpha Limited

FORM 8.5 (EPT/RI)

Salg af kontraktrettighed – Victor Froholdt

F.C. København har indgået aftale om salg af kontraktrettigheden på Victor Froholdt til FUTEBOL CLUBE DO PORTO.

Rakovina Therapeutics KT-5000AI Program Yields Potent ATR Inhibitor Hits in Early Screening

Compounds developed through collaboration with Variational AI show targeted activity 
Compounds developed through collaboration with Variational AI show targeted activity

Getchell Gold Corp. Commences Drill Program at Fondaway Canyon, Nevada

VANCOUVER, BC, July 23, 2025 /CNW/ - Getchell Gold Corp. (CSE: GTCH) (OTCQB: GGLDF) (FWB: GGA1) ("Getchell" or the "Company") is pleased to announce...

Singapore-Based Innovative Biomedical Start-Up Achieves ‘Strategic Triumph’ to Conquer Chinese Med-Tech Market

NMPA grants Syntellix product approval for the world's most important future market with more than 1.4 billion people Syntellix' product approval for China...

Man Group PLC : Form 8.3 – Deliveroo Plc

FORM 8.3

Singapore-Based Innovative Biomedical Start-Up Achieves ‘Strategic Triumph’ to Conquer Chinese Med-Tech Market

NMPA grants Syntellix product approval for the world's most important future market with more than 1.4 billion people Syntellix' product approval for China...

NetDragon Achieves “A” Rating in Wind ESG Assessment, Demonstrating Strong Commitment to Sustainable Development Principles

HONG KONG, July 23, 2025 /PRNewswire/ -- NetDragon Websoft Holdings Limited ("NetDragon" or the "Company", Hong Kong Stock Code: 777), a global leader in building...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTags1

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers